We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.89%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+40.89%
3 Year Est. Return
+115.82%
5 Year Est. Return
+132.07%
10 Year Est. Return
+517.81%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
+$4.43B
Cap. Flow %
4.04%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,445
Increased
2,647
Reduced
3,047
Closed
1,267
Avg Time Held Equity + Options
6.9 quarters
Top 10 Avg Time Held Equity + Options
5.6 quarters
Top 20 Avg Time Held Equity + Options
5 quarters
Avg Time Held Equity only
4.8 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.22%
2 Technology 7.41%
3 Consumer Discretionary 6.04%
4 Financials 5.89%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GNSS icon
7101
Genasys
GNSS
$66M
$18K ﹤0.01%
+12,216
New +$19.7K
2017 Q1
0 quarters
KZIA
7102
Kazia Therapeutics
KZIA
$144M
$18K ﹤0.01%
+64
New +$20.2K
2017 Q1
0 quarters
PLX icon
7103
PUT
Protalix BioTherapeutics
PLX
$218M
$18K ﹤0.01%
+1,350
New +$12.1K
2017 Q1
0 quarters
WPRT
7104
CALL
Westport Fuel Systems
WPRT
$35.7M
$18K ﹤0.01%
1,880
-5,390
-74% -$59K
2013 Q2
15 quarters
FNJN
7105
DELISTED
Finjan Holdings, Inc.
FNJN
$18K ﹤0.01%
+10,123
New +$14.5K
2017 Q1
0 quarters
SDT
7106
PUT
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
$18K ﹤0.01%
13,000
-16,200
-55% -$24.5K
2016 Q2
3 quarters
RHE
7107
DELISTED
Regional Health Properties, Inc.
RHE
$18K ﹤0.01%
+1,150
New +$19.9K
2017 Q1
0 quarters
EVEP
7108
CALL
DELISTED
EV Energy Partners, L.P.
EVEP
$18K ﹤0.01%
12,300
-18,700
-60% -$33.5K
2016 Q3
2 quarters
CGNT
7109
DELISTED
Cogentix Medical, Inc.
CGNT
$18K ﹤0.01%
+10,200
New +$20.2K
2017 Q1
0 quarters
UNXL
7110
DELISTED
Uni-Pixel, Inc.
UNXL
$18K ﹤0.01%
21,129
-16,164
-43% -$17.8K
2016 Q3
2 quarters
XCO
7111
CALL
DELISTED
Exco Resources
XCO
$18K ﹤0.01%
1,960
-7,840
-80% -$80.1K
2014 Q1
12 quarters
ADPT
7112
CALL
DELISTED
Adeptus Health Inc
ADPT
$18K ﹤0.01%
+10,000
New +$56.1K
2017 Q1
0 quarters
TIO
7113
DELISTED
Tingo Group, Inc. Common Stock
TIO
$18K ﹤0.01%
+15,624
New +$20.3K
2017 Q1
0 quarters
CIVI
7114
PUT
DELISTED
Civitas Resources
CIVI
$17K ﹤0.01%
132
+26
+25% +$5.23K
2014 Q3
10 quarters
ENLV icon
7115
Enlivex Ltd
ENLV
$7.71M
$17K ﹤0.01%
+38
New +$25K
2017 Q1
0 quarters
LIQT icon
7116
LiqTech
LIQT
$17.2M
$17K ﹤0.01%
1,334
+509
+62% +$8.27K
2016 Q4
1 quarter
MLSS icon
7117
Milestone Scientific
MLSS
$34.3M
$17K ﹤0.01%
+12,787
New +$17.9K
2017 Q1
0 quarters
SLNO
7118
DELISTED
Soleno Therapeutics
SLNO
$17K ﹤0.01%
+327
New +$19.3K
2017 Q1
0 quarters
TAIT
7119
DELISTED
Taitron Components
TAIT
$17K ﹤0.01%
14,125
-3,440
-20% -$4.07K
2016 Q2
3 quarters
TRX icon
7120
TRX Gold Corp
TRX
$393M
$17K ﹤0.01%
40,359
-6,070
-13% -$3.05K
2015 Q4
5 quarters
VERU icon
7121
Veru
VERU
$42.8M
$17K ﹤0.01%
+1,671
New +$17.3K
2017 Q1
0 quarters
CDMO
7122
PUT
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$17K ﹤0.01%
3,786
+2,329
+160% +$7.8K
2016 Q4
1 quarter
MMAT
7123
DELISTED
Meta Materials Inc. Common Stock
MMAT
$17K ﹤0.01%
+61
New +$18K
2017 Q1
0 quarters
SDPI
7124
DELISTED
Superior Drilling Products Inc.
SDPI
$17K ﹤0.01%
+18,710
New +$19.1K
2017 Q1
0 quarters
TGA
7125
CALL
DELISTED
Transglobe Energy Corp
TGA
$17K ﹤0.01%
+10,600
New +$17.8K
2017 Q1
0 quarters

Similar funds

Citadel Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.

  • Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.